Ironwood Pharmaceuticals Prices $136.5 Million Stock Offering
5/22/2013
More...
|
INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug
5/21/2013
More...
|
Ambit Biosciences Cuts IPO Price
5/16/2013
More...
|
Quintiles, Inc. (QTRN) Celebrates IPO on the New York Stock Exchange
5/10/2013
More...
|
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire
5/10/2013
More...
|
Receptos Announces Pricing of Initial Public Offering of Common Stock
5/9/2013
More...
|
INSYS Therapeutics Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option
5/7/2013
More...
|
San Diego's Receptos, Ambit Biosciences, Get Ready for IPO Debuts
5/7/2013
More...
|
INSYS Therapeutics Announces Pricing of IPO
5/2/2013
More...
|
TPG-Backed Quintiles, Inc. (QTRN) Outlines $790 Million Price in IPO
4/26/2013
More...
|
Omthera Pharmaceuticals, Inc. Prices Upsized IPO Below the Range at $8
4/11/2013
More...
|
Harvard Apparatus Postpones $19 Million IPO
4/10/2013
More...
|
Chimerix, Inc. Sets Terms for $85 Million IPO
4/2/2013
More...
|
Enanta Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option
3/27/2013
More...
|
Enanta Pharmaceuticals, Inc. Raises $56 Million in IPO
3/21/2013
More...
|
Zoetis (ZTS) Closes Initial Public Offering
2/7/2013
More...
|
KaloBios Pharmaceuticals, Inc. Completes Initial Public Offering
2/7/2013
More...
|
Pfizer Inc. (PFE)'s Zoetis (ZTS) Hauls in $2.24 Billion in IPO
2/1/2013
More...
|
Stemline Therapeutics, Inc. (STML) Announces Closing of Initial Public Offering
2/1/2013
More...
|
Stemline Therapeutics, Inc. (STML) Rises in Its Market Debut as First Biotech IPO of 2013
1/30/2013
More...
|
KaloBios Pharmaceuticals, Inc. on Path Toward $50 Million IPO
1/28/2013
More...
|
Vantiv Succeeds With IPO, Begins Rapid Acquisitions
12/28/2012
More...
|
Cancer Drug Spinoff of Australian Company, Audeo Oncology Inc. Preps $49 Million IPO
12/10/2012
More...
|
Puma Biotechnology Raises $138 Million in Public Offering of Common Stock
10/26/2012
More...
|
BioIndustry Association Release: Latest French Biotech IPO Demonstrates the Potential of Citizens' Innovation Funds
10/25/2012
More...
|
ImmunoCellular Therapeutics, Ltd Announces Pricing of its Previously Announced Public Offering of Common Stock and Warrants
10/18/2012
More...
|
Anacor Pharmaceuticals, Inc. Prices $24 Million Public Offering of Common Stock
10/18/2012
More...
|
MannKind Corporation (MNKD) Prices Offering at 23 Pct Discount
10/18/2012
More...
|
Kythera Biopharmaceuticals Announces Closing of Initial Public Offering and Exercise of Underwriters’ Over-Allotment Option
10/16/2012
More...
|
Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs
10/12/2012
More...
|
Intercept Pharmaceuticals Announces Pricing of Initial Public Offering
10/11/2012
More...
|
Kythera Biopharmaceuticals Announces Pricing of Initial Public Offering
10/11/2012
More...
|
Isis Pharmaceuticals, Inc. (ISIS) Investment in Regulus Therapeutics, Inc. Valued at $28 Million at Completion of Regulus Initial Public Offering
10/11/2012
More...
|
Fosun Pharma's Hong Kong IPO Set to Raise $600 Million
10/5/2012
More...
|
Regulus Therapeutics, Inc. Announces Pricing of Initial Public Offering
10/4/2012
More...
|
Kythera Biopharmaceuticals Prices IPO
9/28/2012
More...
|
GlobeImmune, Inc. Offers IPO Details
9/6/2012
More...
|
China National Biotech Group Approved for $1.6 Billion Hong Kong IPO
9/6/2012
More...
|
The Week in Review: Tigermed and Shuangcheng Pharma Complete IPOs
8/21/2012
More...
|
Tigermed Completes $80 Million IPO on the ChiNext Exchange
8/20/2012
More...
|
Fluidigm Corporation Prices $52.2 Million Public Offering of Common Stock
8/16/2012
More...
|
Hainan Shuangcheng Pharma Stages $94 Million IPO in Shenzhen
8/15/2012
More...
|
Stemline Therapeutics, Inc. Postpones IPO
8/9/2012
More...
|
Hyperion Therapeutics Completes Initial Public Offering and Announces Exercise of Underwriters' Over-Allotment Option
8/1/2012
More...
|
Idenix Pharmaceuticals, Inc. (IDIX) Announces Proposed Public Offering of Common Stock
8/1/2012
More...
|
Hyperion Therapeutics Prices IPO at $10.00, Below the Range Expected
7/26/2012
More...
|
Durata Therapeutics, Inc. Closes Initial Public Offering
7/25/2012
More...
|
Zogenix, Inc. Prices Public Offering of Common Stock and Warrants to Purchase Common Stock
7/24/2012
More...
|
Durata Therapeutics, Inc. Prices $68 Million IPO
7/19/2012
More...
|
Tesaro, Inc. Announces Pricing of Initial Public Offering
6/28/2012
More...
|
Tesaro, Inc. Sets Terms for $81 Million US IPO
6/20/2012
More...
|
Cathay Industrial Biotech Withdraws $90 Million IPO
6/13/2012
More...
|
After Successful IPO, Verastem, Inc. (VSTM) Tries to Deliver on Promise
5/24/2012
More...
|
Cancer Genetics, Inc. Delays IPO to Avoid Faceoff with Facebook
5/21/2012
More...
|
China National Biotech Group to Raise $1.6 Billion in Hong Kong IPO
5/18/2012
More...
|
Rib-X Pharmaceuticals, Inc. Postpones IPO After Slashing Price by 50 Pct
5/11/2012
More...
|
Dynavax Technologies Corporation (DVAX) Sinks on Discounted Offering, CEO Exit
5/9/2012
More...
|
Supernus Pharmaceuticals Prices IPO at $5, Raising $50 Million
5/1/2012
More...
|
Fosun Pharma Given OK for Hong Kong IPO
4/12/2012
More...
|
Supernus Pharmaceuticals Sets Terms for $75 Million US IPO
4/12/2012
More...
|
Shares of Merrimack Pharmaceuticals Inc. Stock Drops Post - IPO
3/30/2012
More...
|
Merrimack Pharmaceuticals Inc. Sets New IPO Terms, Aiming to Raise Less $
3/28/2012
More...
|
Pfizer Inc. (PFE) Mulls $3 Billion Partial IPO for Animal Healthcare Unit: Report
2/21/2012
More...
|
Beijing Leadman Biochemistry Completes ChiNext IPO
2/16/2012
More...
|
ChemoCentryx, Inc. Completes IPO
2/14/2012
More...
|
Chinese Drugmaker Guizhentang Pharmaceuticals' IPO Protested Over Bear Bile
2/13/2012
More...
|
Merrimack Pharmaceuticals Inc. Scraps IPO Plans
2/2/2012
More...
|
Verastem, Inc. Bucks the Trend, Raises $55 Million in IPO
1/27/2012
More...
|
ChemoCentryx, Inc. Sets $14-$16 Range for IPO
1/26/2012
More...
|
Xizang Haisco Pharma Completes $127 Million IPO
1/17/2012
More...
|
Verastem, Inc. 4.5 Million-Share IPO Seen Pricing at $9-$11 a Piece
1/17/2012
More...
|
Clovis Oncology (CLVS) Raises $130 Million in IPO
11/16/2011
More...
|
NewLink Genetics Raises $43.4 Million in IPO
11/11/2011
More...
|
China National Biotech Group's Hong Kong IPO to Raise Up to $2 Billion
11/9/2011
More...
|
Clovis Oncology Poised for IPO, Targets $13 to $15 Per Share
11/2/2011
More...
|
NewLink Genetics Estimates it Will Raise $53.4 Million From IPO
10/27/2011
More...
|
Sinocom Pharma Withdraws IPO Plans, Cites Market Conditions
10/14/2011
More...
|
Horizon Pharma, Inc. Announces Pricing of Its Initial Public Offering
7/28/2011
More...
|
Shijiazhuang Yiling Pharmaceutical Climbs in Post-IPO Trading
7/28/2011
More...
|
Tranzyme Pharma Announces Partial Exercise of Over-Allotment Option for Initial Public Offering
5/5/2011
More...
|
Sagent Pharmaceuticals, Inc. Announces Closing of 5.75M Share IPO
4/27/2011
More...
|
Sagene Pharmaceuticals, Inc. Prices IPO at $16 Per Share, Raises $92 Million in Gross Proceeds
4/20/2011
More...
|
Tranzyme Pharma Announces Pricing of Its Initial Public Offering, Raises $53.8M
4/4/2011
More...
|
U.S. HIV Drug Firm Koronis Pharmaceuticals, Inc. Looks to London Listing
3/14/2011
More...
|
AcelRx Pharmaceuticals Prices IPO at $5, Below the Original $12-$14 Range
2/11/2011
More...
|
RedHill Biopharma Ltd. Announces Successful Completion of IPO
2/7/2011
More...
|
MedQuist Holdings Inc. Announces Pricing of Its Initial Public Offering
2/7/2011
More...
|
ShangPharma Offering Up To $52.8 Million In IPO; Towards the Lower End of Intially Stated Range
10/19/2010
More...
|
CRO ShangPharma Plans $90 Million IPO on the NYSE
10/5/2010
More...
|
Yunnan Walvax Biotech to IPO on ChiNext Exchange
9/14/2010
More...
|
Cholesterol-Drug Developer Aegerion Pharmaceuticals, Inc. Revives Plan for $86.3M IPO
8/11/2010
More...
|
NuPathe Inc. Prices Shares of IPO at Scaled-back Price, Raising $50 Million
8/6/2010
More...
|
Trius Therapeutics Decreases Size of IPO Deal from $78M to $49M
8/3/2010
More...
|
China Pharma IPOs Raise $5.4 Billion in 12 Months
7/26/2010
More...
|
Aposense Ltd. (Formerly known as NST NeuroSurvival Technologies Ltd.) Announces Successful Completion of IPO
6/16/2010
More...
|
Alimera Sciences (ALIM) Prices Low IPO
4/22/2010
More...
|
French Neovasc Inc. (NVC) Cuts IPO Ambitions
4/9/2010
More...
|
Ironwood Pharmaceuticals Chief Executive Breaks Silence on IPO
3/29/2010
More...
|
CorMedix Announces Pricing of Its Initial Public Offering
3/26/2010
More...
|
French Biotech Neovacs SA Targets 20 Million Euros in IPO
3/19/2010
More...
|
AVEO Pharmaceuticals, Inc. (AVEO) Announces Pricing of Its Initial Public Offering
3/12/2010
More...
|
Anthera Pharmaceuticals, Inc. (JOBS) IPO Closes Up 1 Cent in The Nasdaq Stock Market -- New York Debut
3/2/2010
More...
|
Anthera Pharmaceuticals, Inc. (ANTH) (JOBS) IPO Postponed; Price Reduced
2/25/2010
More...
|
AVEO Pharmaceuticals, Inc. (AVEO) Sets IPO Terms
2/24/2010
More...
|
Fidelity-Backed Fluidigm Corporation May Delay IPO as Startup Deals Falter
2/22/2010
More...
|
Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals' Initial Public Offering
2/16/2010
More...
|
Anthera Pharmaceuticals, Inc. Sets IPO Terms, Will Price in the $13-$15 Per Share Range
2/3/2010
More...
|
AB Science Preparing Paris IPO; 50 Million Euro IPO Seen Beginning of March
2/3/2010
More...
|
Ironwood Pharmaceuticals Expects $272 Million In IPO Planned Wednesday
1/29/2010
More...
|
Ironwood Pharmaceuticals Sets IPO Price at $14-$16 Per Share to Raise Between $233 Million and $267 Million
1/20/2010
More...
|
JSC Human Stem Cell Institute Announces IPO Price Range for Initial Public Offering
10/7/2009
More...
|
Medidata Solutions, Inc. Prices Initial Public Offering
6/25/2009
More...
|
Fluidigm Corporation Withdraws Its Registration Statement for Initial Public Offering
9/26/2008
More...
|
EpiCept Corporation (EPCT) Announces Pricing of Public Offering
8/4/2008
More...
|
Cornell Companies (CRN) Files $75 Million Shelf Registration Statement
8/1/2008
More...
|
Fluidigm Corporation Files Registration Statement for Proposed Initial Public Offering
4/16/2008
More...
|
EpiCept Corporation (EPCT) Announces Pricing of Public Offering
3/6/2008
More...
|
Zeltia Group (18494051.MA) Says Yondelis on Track, Delays Neuropharma Unit IPO
3/6/2008
More...
|
Bioheart, Inc. Announces Pricing of Initial Public Offering and Commencement of Trading
2/19/2008
More...
|
Elixir Pharmaceuticals Sees IPO of 5 Million Shares at $14-$16 each
12/18/2007
More...
|
ATEL Ventures Portfolio Company, ARYx Therapeutics, Inc. Completes Initial Public Offering
12/6/2007
More...
|
ARYx Therapeutics, Inc. IPO Raises $50 Million
11/7/2007
More...
|
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Closes Initial Public Offering of Common Stock
10/31/2007
More...
|
Merrion Pharmaceuticals, Inc. Cuts IPO Price Range to $6-$7 per ADS
10/30/2007
More...
|
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) (Jobs) Raises $20 Million in IPO at $4 Per Share
10/26/2007
More...
|
Reliant Pharmaceuticals, Inc. Sets IPO at 11.7 Million Shares, $25-$27
10/25/2007
More...
|
ARYx Therapeutics, Inc. (Jobs) Sets IPO at 5 Million Shares, $14-$16
10/24/2007
More...
|
ZARS Pharma Withdraws Plans for IPO
10/15/2007
More...
|
Targanta Therapeutics IPO Fails to Fire up Investors
10/11/2007
More...
|
Targanta Therapeutics Announces Pricing of its IPO
10/10/2007
More...
|
MAP Pharmaceuticals, Inc. (MAPP) Announces Pricing of Its Initial Public Offering
10/5/2007
More...
|
MAP Pharmaceuticals, Inc. (Jobs) Sets IPO at 5 Mln Shrs, $14-16
9/21/2007
More...
|
GNI Successfully Completes IPO
9/4/2007
More...
|
WuXi PharmaTech Co., Ltd. Prices IPO above Range
8/9/2007
More...
|
Sucampo Pharmaceuticals, Inc. Says IPO Priced at $11.50 a Share
8/3/2007
More...
|
InterCure Inc. Completes Initial Public Offering on Tel Aviv Stock Exchange
7/31/2007
More...
|
ImaRx Therapeutics Announces Pricing of Its Initial Public Offering
7/26/2007
More...
|
Cumberland Pharmaceuticals Sets 6.25 Million Share IPO
7/24/2007
More...
|
Sucampo Pharmaceuticals, Inc. Sees $14-$16/Share Price Band for IPO
7/17/2007
More...
|